Speaker Profile
PhD, President & Division Head, Gene Therapy Research & Technical Operations, Astellas
Biography
Morten Sogaard is President, Research TechOps at Astellas Gene Therapies. Morten oversees Research and nonGMP CMC in South SF and Japan with a remit to deliver 2 clinical gene therapy candidates p.a. Before Astellas Morten led human genetics, functional genomics, CompBio and diagnostics functions as Global Head of Genome Sciences and a member of Pfizer's RD LT, and later led Target Sciences. He also headed up Search Evaluation for Platform Technologies and Oncology. Morten started his industry career at Pharmacia (Sweden), where he oversaw NextGen immunooncology antibody therapeutics. Later at AZ he led Molecular Sciences providing biologics and genomics capabilities to TAs. 2004, Morten moved to BI (CT) as global head, enabling technology, building a companywide platform of global skill centers, research informatics and briefly served as Head of RD Informatics. Morten received his Ph.D. in Biochemistry from Univ. of Copenhagen and did postdoctoral studies at MSKCC.
Session Abstract – PMWC 2024 Silicon Valley
Track Co-Chairs:
Yael Weiss, Mahzi Tx
Peter Marks, FDA
- PMWC 2024 Award Ceremony
Pioneer Honoree: Katherine A. High, AskBio
Pioneer Honoree: Timothy Yu, Boston Children's Hospital
- Piloting Interventional Genomics for Orphan Diseases
Keynote: Timothy Yu, Boston Children's Hospital
- Accelerated Approval for Small Populations: Biomarkers & Endpoints (PANEL)
Chair: Peter Marks, FDA
- Jennifer Puck, UCSF
- Maria Grazia Roncarolo, Tr1X
- Katherine A. High, Rockefeller University
- Jennifer Panagoulias, FAST (Angelman Syndrome Foundation)
- Timothy Yu, Boston Children's Hospital - Novel Clinical Design Approaches in Rare Diseases (PANEL)
Chair: Adam Shaywitz, Bridge Bio
- Salvador Rico, Encoded Therapeutics
- Eric Crombez, Ultragenyx
- Elizabeth Berri Kravis, Rush University
- Empowering Patient Advocacy in Rare Disease Therapies (PANEL)
Chair: Yael Weiss, Mahzi Tx
- Justin West, KCNT1 Foundation
- Michael Graglia, Syngap Research Fund
- Wendy Erler, Alexion Pharmaceuticals - Advancing the Frontier: Gene Editing for Rare Diseases (PANEL)
Chair: Matthew Porteus, Stanford
- James Chung, Kyverna Therapeutics
- Lucas Harrington, Mammoth Biosciences
- Aron Stein, Intellia Therapeutics - Advancing the Frontier: Gene and Cell Therapies for Rare Diseases (PANEL)
Chair: Morten Sogaard, Astellas Gene Therapies
- Pooja Agarwal, BioMarin Pharmaceutical
- David Kirn, 4dmt
- Adrian Veres, Dyno Therapeutics
- Thomas Wechsler, J&J
- PMWC Showcase
- Dominic Borie, Kyverna Therapeutics
